The intricate landscape of the 340B space has reached unprecedented levels of complexity, with an array of conflicts and challenges emerging from various fronts. Navigating through the expanding manufacturer restrictions, staying updated on pivotal legal cases, CMS rule modifications, the enigmatic extent of HRSA enforcement authority, and the potential 9 billion dollar lump sum disbursements to 340B hospitals has become an enduring task. In this dynamic environment, Advis recognizes the mounting difficulty for 340B stakeholders to effectively optimize their programs while adhering to regulations.
It is more important than ever to implement effective 340B cost saving and compliant optimization solutions that consider the benefits and risks associated with the 340B space today. Our 340B in 2023 Whitepaper explores several 340B hot topics to highlight some of the biggest obstacles facing 340B covered entities today, and offer insight into strategies and best practices to combat the current uncertainty.
If you have any questions regarding any of the areas addressed in this whitepaper or your 340B program, please contact Advis today or call (708) 478-7030 for assistance in navigating these challenges.
Published: August 18, 2023
PGlmcmFtZSBzdHlsZT0iYm9yZGVyOiAwOyIgc3JjPSJodHRwczovL3d3dzIuYWR2aXMuY29tL2wvNDc0MjgyLzIwMjMtMDgtMTgvajFzeHZuIiBoZWlnaHQ9IjUwMCIgZnJhbWVib3JkZXI9IjAiPjwvaWZyYW1lPg==
